Identification of Natural Molecular Determinants of Ross River Virus Type I Interferon Modulation

被引:5
|
作者
Liu, Xiang [1 ,2 ]
Mutso, Margit [1 ,2 ]
Cherkashchenko, Liubov [3 ]
Zusinaite, Eva [3 ]
Herrero, Lara J. [1 ]
Doggett, Stephen L. [4 ]
Haniotis, John [4 ]
Merits, Andres [3 ]
Herring, Belinda L. [1 ]
Taylor, Adam [1 ,2 ]
Mahalingam, Suresh [1 ,2 ]
机构
[1] Griffith Univ, Inst Glyc, Southport, Qld, Australia
[2] Griffith Univ, Menzies Hlth Inst Queensland, Southport, Qld, Australia
[3] Univ Tartu, Inst Technol, Tartu, Estonia
[4] Westmead Hosp, Dept Med Entomol, ICPMR, Pathol West, Westmead, NSW, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Ross River virus; alphavirus; interferons; viral determinants; SINDBIS VIRUS; CHIKUNGUNYA VIRUS; ALPHA/BETA-INTERFERON; NONSTRUCTURAL PROTEIN-2; HEMORRHAGIC-FEVER; MINUS-STRAND; MOUSE MODEL; RNA; REPLICATION; MUTATIONS;
D O I
10.1128/JVI.01788-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Ross River virus (RRV) belongs to the genus Alphavirus and is prevalent in Australia. RRV infection can cause arthritic symptoms in patients and may include rash, fever, arthralgia, and myalgia. Type I interferons (IFN) are the primary antiviral cytokines and trigger activation of the host innate immune system to suppress the replication of invading viruses. Alphaviruses are able to subvert the type I IFN system, but the mechanisms used are ill defined. In this study, seven RRV field strains were analyzed for induction of and sensitivity to type I IFN. The sensitivities of these strains to human IFN-/3 varied significantly and were highest for the RRV 2548 strain. Compared to prototype laboratory strain RRV-T48, RRV 2548 also induced higher type I IFN levels both in vitro and in vivo and caused milder disease. To identify the determinants involved in type I IFN modulation, the region encoding the nonstructural proteins (nsPs) of RRV 2548 was sequenced, and 42 amino acid differences from RRV-T48 were identified. Using fragment swapping and site-directed mutagenesis, we discovered that substitutions E402A and R522Q in nsP1 as well as Q619R in nsP2 were responsible for increased sensitivity of RRV 2548 to type I IFN. In contrast, substitutions A31T, N219T, S580L, and Q619R in nsP2 led to induction of higher levels of type I IFN. With exception of E402A, all these variations are common for naturally occurring RRV strains. However, they are different from all known determinants of type I IFN modulation reported previously in nsPs of alphaviruses. IMPORTANCE By identifying natural Ross River virus (RRV) amino acid determinants for type I interferon (IFN) modulation, this study gives further insight into the mechanism of type I IFN modulation by alphaviruses. Here, the crucial role of type I IFN in the early stages of RRV disease pathogenesis is further demonstrated. This study also provides a comparison of the roles of different parts of the RRV nonstructural region in type I IFN modulation, highlighting the importance of nonstructural protein 1 (nsP1) and nsP2 in this process. Three substitutions in nsP1 and nsP2 were found to be independently associated with enhanced type I IFN sensitivity, and four independent substitutions in nsP2 were important in elevated type I IFN induction. Such evidence has clear implications for RRV immunobiology, persistence, and pathology. The identification of viral proteins that modulate type I IFN may also have importance for the pathogenesis of other alphaviruses.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Ross river virus evasion of type I interferons
    Shabman, Reed S.
    Morrison, Thomas E.
    White, Laura
    Suthar, Mehul S.
    Madric, Kenya
    Mahalingam, Suresh
    Lidburyl, Brett
    Moore, Christopher
    Heise, Mark T.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 193 - 193
  • [2] Ross River Virus Envelope Glycans Contribute to Type I Interferon Production in Myeloid Dendritic Cells
    Shabman, Reed S.
    Rogers, Kristin M.
    Heise, Mark T.
    JOURNAL OF VIROLOGY, 2008, 82 (24) : 12374 - 12383
  • [3] INTERFERON TREATMENT OF EXPERIMENTAL ROSS RIVER VIRUS POLYMYOSITIS
    SEAY, AR
    KERN, ER
    MURRAY, RS
    NEUROLOGY, 1987, 37 (07) : 1189 - 1193
  • [4] Identification and Characterization of a Ross River Virus Variant That Grows Persistently in Macrophages, Shows Altered Disease Kinetics in a Mouse Model, and Exhibits Resistance to Type I Interferon
    Lidbury, Brett A.
    Rulli, Nestor E.
    Musso, Cristina M.
    Cossetto, Susan B.
    Zaid, Ali
    Suhrbier, Andreas
    Rothenfluh, Harald S.
    Rolph, Michael S.
    Mahalingam, Suresh
    JOURNAL OF VIROLOGY, 2011, 85 (11) : 5651 - 5663
  • [5] Dual Modulation of Type I Interferon Response by Bluetongue Virus
    Doceul, Virginie
    Chauveau, Emilie
    Lara, Estelle
    Breard, Emmanuel
    Sailleau, Corinne
    Zientara, Stephan
    Vitour, Damien
    JOURNAL OF VIROLOGY, 2014, 88 (18) : 10792 - 10802
  • [6] Modulation of Type I Interferon System by African Swine Fever Virus
    Razzuoli, Elisabetta
    Franzoni, Giulia
    Carta, Tania
    Zinellu, Susanna
    Amadori, Massimo
    Modesto, Paola
    Oggiano, Annalisa
    PATHOGENS, 2020, 9 (05):
  • [7] Osteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses
    Weiqiang Chen
    Suan-Sin Foo
    Rachel W Li
    Paul N Smith
    Suresh Mahalingam
    Virology Journal, 11
  • [8] Osteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses
    Chen, Weiqiang
    Foo, Suan-Sin
    Li, Rachel W.
    Smith, Paul N.
    Mahalingam, Suresh
    VIROLOGY JOURNAL, 2014, 11
  • [9] EFFECTS OF INTERFERON TREATMENT ON EXPERIMENTAL ROSS RIVER VIRUS-INFECTION
    SEAY, AR
    MURRAY, RS
    KERN, ER
    DEKORVER, LL
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1984, 43 (03): : 333 - 333
  • [10] Molecular determinants of human immunodeficiency virus type I phenotype variability
    Fouchier, RAM
    Schuitemaker, H
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (03) : 175 - 185